Nanoparticle Based Gene Therapy Approach: A Pioneering Rebellion in the Management of Psychiatric Disorders.

Current Gene Therapy
Saleha RehmanJaved Ali

Abstract

The neuropsychiatric illnesses have been enigmatic, with no effective treatment to date. The complexity and heterogeneity of psychiatric disorders are daunting for the development of novel treatment modalities. The conventional treatment approaches are less effective and are associated with several side effects, thus creating the need for the development of more innovative strategies. Since psychiatric disorders are known to exhibit genetic linkage, gene therapy has created an interest among the researchers worldwide. The delivery of nucleic acids is a complex process requiring the transport of genetic material across various intracellular and extracellular barriers to reach the target cells eliciting the transfection process. Therefore, the identification or development of the delivery system for nucleic acid delivery still remains the challenge. Viral vectors are quite effective but are associated with toxicity and side effects. With the rapid advancement in the field of nanotechnology, nanosized materials were identified to be the perfect candidate for nonviral vectors in gene delivery. The biggest advantage of nanoparticles is that their surface can be engineered in many possible ways to deliver the drugs directly to the ta...Continue Reading

References

Feb 4, 2003·The American Journal of Psychiatry·Robert M Sapolsky
Feb 22, 2005·Advanced Drug Delivery Reviews·Mattias BeltingAnders Wittrup
Jan 27, 2007·Bioconjugate Chemistry·Giovanna MontanaMarta Di Carlo
May 19, 2009·Nanomedicine : Nanotechnology, Biology, and Medicine·Yosuke ObataShinji Takeoka
Nov 17, 2009·Journal of the Neurological Sciences·Rongqin HuangYuanying Pei
Dec 19, 2009·Expert Opinion on Drug Delivery·Maria Luisa Bondì, Emanuela Fabiola Craparo
Mar 23, 2011·Nature Biotechnology·Lydia Alvarez-ErvitiMatthew J A Wood
Jun 7, 2011·Annual Review of Biomedical Engineering·Leaf Huang, Yang Liu
Nov 22, 2011·Advanced Drug Delivery Reviews·Ho Lun WongReina Bendayan
Dec 17, 2011·Journal of Drug Delivery·Ruben J Boado, William M Pardridge
Jan 19, 2012·Molecular Therapy : the Journal of the American Society of Gene Therapy·Rosemary L KanastyDaniel G Anderson
Jan 26, 2012·Recent Patents on Drug Delivery & Formulation·Carlos SpuchCarmen Navarro
Mar 13, 2012·Pharmacological Reviews·Anita E Autry, Lisa M Monteggia
Apr 5, 2012·Molecular Psychiatry·UNKNOWN Major Depressive Disorder Working Group of the Psychiatric GWAS ConsortiumPatrick F Sullivan
Jun 19, 2012·Nucleic Acid Therapeutics·Nicholas M Snead, John J Rossi
Jul 4, 2012·Brain Research·Hae-Young Lopilly ParkChan Kee Park
Dec 27, 2012·World Neurosurgery·Yaroslav Gelfand, Michael G Kaplitt
May 3, 2013·Frontiers in Genetics·Carrie WrightNora Perrone-Bizzozero
Jul 31, 2013·Drug Discovery Today·Angelina AngelovaSylviane Lesieur
Aug 13, 2013·Nature Genetics·UNKNOWN Cross-Disorder Group of the Psychiatric Genomics ConsortiumUNKNOWN International Inflammatory Bowel Disease Genetics Consortium (IIBDGC)
Jun 7, 2014·Annual Review of Biomedical Engineering·John-Michael WillifordHai-Quan Mao
Jun 18, 2014·Nanoscale Research Letters·Solmaz Maleki DizajAhmad Yari Khosroushahi
Jul 16, 2014·Nature Reviews. Genetics·Hao YinDaniel G Anderson
Aug 6, 2014·Journal of Controlled Release : Official Journal of the Controlled Release Society·Roy van der MeelRaymond M Schiffelers
Aug 7, 2014·Clinical and Translational Medicine·Alexander AleynikPranela Rameshwar
Nov 21, 2014·Advances in Genetics·Yi Zhao, Leaf Huang
Nov 21, 2014·Advances in Genetics·Alex K K LeungPieter R Cullis
Feb 18, 2015·Applied Biochemistry and Biotechnology·Guang-Feng LiJian-Dong Yang
Mar 5, 2015·Journal of Clinical and Diagnostic Research : JCDR·Murali Ramamoorth, Aparna Narvekar
Mar 13, 2015·Advanced Healthcare Materials·Panagiotis MastorakosJustin Hanes
Mar 20, 2015·Drug Delivery and Translational Research·C WanP R Cullis
Aug 8, 2015·Anais Da Academia Brasileira De Ciências·Gabriela D ColpoAdriane R Rosa
Nov 6, 2015·BioMed Research International·Sudheendra RaoDamien D Pearse
Nov 27, 2015·Advanced Materials·Mijanur Rahaman Molla, Pavel A Levkin
Dec 8, 2015·Expert Opinion on Biological Therapy·Chi-Jing ChoongHideki Mochizuki
Dec 15, 2015·Nature Reviews. Neuroscience·Matthias Heidenreich, Feng Zhang
Feb 20, 2016·Nature Reviews. Neurology·Gerhard LeinengaJürgen Götz
Feb 20, 2016·Journal of Controlled Release : Official Journal of the Controlled Release Society·Reatul KarimGeraldine Piel
Apr 19, 2016·Molecular Therapy. Methods & Clinical Development·Jie ChenXuesi Chen
Jul 3, 2016·Journal of Controlled Release : Official Journal of the Controlled Release Society·Alinda R Fernandes, Divya M Chari

❮ Previous
Next ❯

Citations

Oct 16, 2020·Current Gene Therapy·Ghulam Md Ashraf, Md Sahab Uddin

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Journal of Controlled Release : Official Journal of the Controlled Release Society
M HaiderH Ghandehari
Recent Patents on DNA & Gene Sequences
Amit K GoyalSuresh P Vyas
Journal of Materials Chemistry. B, Materials for Biology and Medicine
Ziyao KangKeliang Liu
© 2022 Meta ULC. All rights reserved